Abstract:Neurodegenerative diseases such as Alzheimer's disease (AD) are still an important issue for scientists because it is difficult to cure with the available molecular medications and conventional treatments. Due to the complex nature of the brain structures and heterogeneous morphological and physiological properties of neuronal cells, interventions for cerebral-related disorders using surgical approaches, and classical and ongoing treatments remain hard for physicians. Furthermore, the development of newly designed medications attempts to target AD are not successful in improving AD, because abnormalities of tau protein, aggregation of amyloid β (Aβ) peptide, inflammatory responses, etc lead to advanced neurodegeneration processes that conventional treatments cannot stop them. In recent years, novel diagnostic strategies and therapeutic approaches have been developed to identify and cure early pathological events of AD. Accordingly, many gene-based therapies have been developed and introduce the therapeutic potential to prevent and cure AD. On the other hand, genetic investigations and postmortem assessments have detected a large number of factors associated with AD pathology. Also, genetically diverse animal models of AD help us to detect and prioritize novel resilience mechanisms. Hence, gene therapy can be considered an effective and powerful tool to identify and treat human diseases. Ultimately, gene study and gene-based therapy with a critical role in the detection and cure of various human disorders will have a fundamental role in our lives forever. This scientific review paper discusses the present status of different therapeutic strategies, particularly gene-based therapy in treating AD, along with its challenges.

[Development of Gene Therapy in Major Brain Diseases].

The Potential Application of Gene Therapy in the Treatment of Traumatic Brain Injury

Current developments of gene therapy in human diseases

Gene Therapy in Cerebrovascular Diseases

Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases

Gene Therapy for Neurodegenerative Disorders: Advances, Insights and Prospects

Non-viral gene delivery and therapeutics targeting to brain

Present Insights into the progress in gene therapy delivery systems for central nervous system diseases

Advance in Gene Therapy of Tumors

Gene therapy for CNS disorders: modalities, delivery and translational challenges

Development of Microrna-Based Therapeutics for Central Nervous System Diseases.

Progress on brain-targeting non-viral gene delivery systems

Gene Therapy:the Present and Prospect

Progress in studies of gene therapy for Huntington's disease

Current Advances in Vehicles for Brain Gene Delivery

Section Review—Oncologic, Endocrine & Metabolic: Gene Therapy Strategies for Cancer

Non‐viral Nucleic Acid Delivery to the Central Nervous System and Brain Tumors

Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy

Advancement and prospects of tumor gene therapy

Viral vectors for gene delivery to the central nervous system

A review of the advances, insights, and prospects of gene therapy for Alzheimer's disease: A novel target for therapeutic medicine